{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:12:12Z","timestamp":1770822732029,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/ncprheum0140","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T12:49:23Z","timestamp":1147783763000},"page":"219-227","source":"Crossref","is-referenced-by-count":96,"title":["Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies"],"prefix":"10.1038","volume":"2","author":[{"given":"Marinos C","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0140_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487\u20131498","journal-title":"N Engl J Med"},{"key":"BFncprheum0140_CR2","first-page":"1321","volume-title":"Myology","author":"AG Engel","year":"2004","unstructured":"Engel AG and Hohlfeld R (2004) The polymyositis and dermatomyositis syndromes. In Myology (edn 3), 1321\u20131366 (Eds Engel AG and Franzini-Armstrong C) New York: McGraw-Hill Book Co."},{"key":"BFncprheum0140_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL and Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am 28: 723\u2013741","journal-title":"Rheum Dis Clin N Am"},{"key":"BFncprheum0140_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC and Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362: 971\u2013982","journal-title":"Lancet"},{"key":"BFncprheum0140_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00019052-200410000-00006","volume":"17","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17: 561\u2013567","journal-title":"Curr Opin Neurol"},{"key":"BFncprheum0140_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","volume":"55","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 55: 1509\u20131512","journal-title":"Arch Neurol"},{"key":"BFncprheum0140_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","volume":"84","author":"BM Koffman","year":"1998","unstructured":"Koffman BM et al. (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84: 139\u2013142","journal-title":"J Neuroimmunol"},{"key":"BFncprheum0140_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","volume":"64","author":"P Price","year":"2004","unstructured":"Price P et al. (2004) Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 64: 575\u2013580","journal-title":"Tissue Antigens"},{"key":"BFncprheum0140_CR9","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","volume":"63","author":"UA Badrising","year":"2004","unstructured":"Badrising UA et al. (2004) Associations with autoimmune disorders and HLA class I, and II antigens in inclusion body myositis. Neurology 63: 2396\u20132398","journal-title":"Neurology"},{"key":"BFncprheum0140_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT et al. (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314: 329\u2013334","journal-title":"N Engl J Med"},{"key":"BFncprheum0140_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC et al. (1993) A controlled trial of high-dose intravenous immunoglobulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993\u20132000","journal-title":"N Engl J Med"},{"key":"BFncprheum0140_CR12","first-page":"81","volume":"151","author":"I Illa","year":"1997","unstructured":"Illa I et al. (1997) Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. Am J Pathol 151: 81\u201388","journal-title":"Am J Pathol"},{"key":"BFncprheum0140_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA et al. (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664\u2013678","journal-title":"Ann Neurol"},{"key":"BFncprheum0140_CR14","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","volume":"168","author":"Z Tezak","year":"2002","unstructured":"Tezak Z et al. (2002) Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154\u20134163","journal-title":"J Immunol"},{"key":"BFncprheum0140_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00002281-200311000-00009","volume":"15","author":"V Askanas","year":"2003","unstructured":"Askanas V and Engel WK (2003) Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging. Curr Opin Rheumatol 15: 737\u2013744","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0140_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.410230111","volume":"23","author":"G Karpati","year":"1988","unstructured":"Karpati G et al. (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23: 64\u201372","journal-title":"Ann Neurol"},{"key":"BFncprheum0140_CR17","first-page":"1142","volume":"143","author":"D Michaelis","year":"1993","unstructured":"Michaelis D et al. (1993) Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 143: 1142\u20131149","journal-title":"Am J Pathol"},{"key":"BFncprheum0140_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","volume":"26","author":"H Wiendl","year":"2005","unstructured":"Wiendl H et al. (2005) Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 26: 373\u2013380","journal-title":"Trends Immunol"},{"key":"BFncprheum0140_CR19","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K et al. (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 97: 9209\u20139214","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0140_CR20","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels N et al. (1996) Differential expression of perforin in muscle-infiltrating T cell in polymyositis and dermatomyositis. J Clin Invest 97: 2905\u20132910","journal-title":"J Clin Invest"},{"key":"BFncprheum0140_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/brain\/awh148","volume":"127","author":"J Schmidt","year":"2004","unstructured":"Schmidt J et al. (2004) Upregulated inducible costimulator and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain 127: 1182\u20131190","journal-title":"Brain"},{"key":"BFncprheum0140_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/brain\/120.6.929","volume":"120","author":"L Behrens","year":"1997","unstructured":"Behrens L et al. (1997) Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 120 (Pt 6): 929\u2013938","journal-title":"Brain"},{"key":"BFncprheum0140_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","volume":"55","author":"C Schneider","year":"1996","unstructured":"Schneider C et al. (1996) MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 55: 1205\u20131209","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncprheum0140_CR24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.152.5.2569","volume":"152","author":"TP O'Hanlon","year":"1994","unstructured":"O'Hanlon TP et al. (1994) Predominant T cell receptor variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 152: 2569\u20132576","journal-title":"J Immunol"},{"key":"BFncprheum0140_CR25","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.4049\/jimmunol.167.6.3521","volume":"167","author":"O Benveniste","year":"2001","unstructured":"Benveniste O et al. (2001) Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomysitis patients. J Immunol 167: 3521\u20133529","journal-title":"J Immunol"},{"key":"BFncprheum0140_CR26","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.4049\/jimmunol.167.7.4051","volume":"167","author":"J Nishio","year":"2001","unstructured":"Nishio J et al. (2001) Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis. J Immunol 167: 4051\u20134058","journal-title":"J Immunol"},{"key":"BFncprheum0140_CR27","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","volume":"123","author":"K Amemiya","year":"2000","unstructured":"Amemiya K et al. (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: studies in repeated muscle biopsies. Brain 123: 2030\u20132039","journal-title":"Brain"},{"key":"BFncprheum0140_CR28","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1073\/pnas.0236183100","volume":"100","author":"M Hofbauer","year":"2003","unstructured":"Hofbauer M et al. (2003) Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR and CDR3 spectratype analysis. Proc Natl Acad Sci USA 100: 4090\u20134095","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0140_CR29","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.161.11.5943","volume":"161","author":"L Behrens","year":"1998","unstructured":"Behrens L et al. (1998) Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 161: 5943\u20135951","journal-title":"J Immunol"},{"key":"BFncprheum0140_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","volume":"155","author":"K Murata","year":"1999","unstructured":"Murata K and Dalakas MC (1999) Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNA in inflammatory myopathies. Am J Pathol 155: 453\u2013460","journal-title":"Am J Pathol"},{"key":"BFncprheum0140_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/awg114","volume":"126","author":"H Wiendl","year":"2003","unstructured":"Wiendl H et al. (2003) Muscle fibers and cultured muscle or cells express the B7.1\/2 related costimulatory molecule ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain 126: 1026\u20131035","journal-title":"Brain"},{"key":"BFncprheum0140_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20020186","volume":"196","author":"OM Howard","year":"2002","unstructured":"Howard OM et al. (2002) Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196: 781\u2013791","journal-title":"J Exp Med"},{"key":"BFncprheum0140_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/mus.10462","volume":"28","author":"D Figarella-Branger","year":"2003","unstructured":"Figarella-Branger D et al. (2003) Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28: 659\u2013682","journal-title":"Muscle Nerve"},{"key":"BFncprheum0140_CR34","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","volume":"58","author":"JL De Bleecker","year":"2002","unstructured":"De Bleecker JL et al. (2002) Differential expression of chemokines in inflammatory myopathies. Neurology 58: 1779\u20131785","journal-title":"Neurology"},{"key":"BFncprheum0140_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","volume":"141","author":"R Raju","year":"2003","unstructured":"Raju R et al. (2003) Expression of interferon-gamma inducible chemokines in the muscles of patients with inclusion body myositis. J Neuroimmunol 141: 125\u2013131","journal-title":"J Neuroimmunol"},{"key":"BFncprheum0140_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1212\/WNL.54.1.65","volume":"54","author":"YC Choi","year":"2000","unstructured":"Choi YC and Dalakas MC (2000) Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54: 65\u201371","journal-title":"Neurology"},{"key":"BFncprheum0140_CR37","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/0140-6736(92)91134-T","volume":"339","author":"RL Leff","year":"1992","unstructured":"Leff RL et al. (1992) Viruses in the idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 339: 1192\u20131195","journal-title":"Lancet"},{"key":"BFncprheum0140_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/ana.410290505","volume":"29","author":"I Illa","year":"1991","unstructured":"Illa I et al. (1991) Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 29: 474\u2013481","journal-title":"Ann Neurol"},{"key":"BFncprheum0140_CR39","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","volume":"119","author":"EJ Cupler","year":"1996","unstructured":"Cupler EJ et al. (1996) Inclusion body myositis in HIV-I and HTLV-I infected patients. Brain 119: 1887\u20131893","journal-title":"Brain"},{"issue":"Suppl","key":"BFncprheum0140_CR40","first-page":"S33","volume":"66","author":"MC Dalakas","year":"2005","unstructured":"Dalakas MC (2005) Inflammatory, immune and viral aspects of inclusion body myositis. Neurology 66 (Suppl): S33\u2013S38","journal-title":"Neurology"},{"key":"BFncprheum0140_CR41","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1128\/JVI.78.19.10320-10327.2004","volume":"78","author":"S Ozden","year":"2004","unstructured":"Ozden S et al. (2004) Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia\/lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol 78: 10320\u201310327","journal-title":"J Virol"},{"key":"BFncprheum0140_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1471-4906(01)01861-0","volume":"22","author":"AG Grandea 3rd","year":"2001","unstructured":"Grandea AG 3rd and Van Kaer L (2001) Tapasin: an ER chaperone that controls MHC class I assembly with peptide. Trends Immunol 22: 194\u2013199","journal-title":"Trends Immunol"},{"key":"BFncprheum0140_CR43","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K et al. (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52: 1824\u20131835","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0140_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnen\/63.5.484","volume":"63","author":"I Ferrer","year":"2004","unstructured":"Ferrer I et al. (2004) Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 63: 484\u2013498","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFncprheum0140_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi G et al. (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164: 1\u20137","journal-title":"Am J Pathol"},{"key":"BFncprheum0140_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.54.5.1033","volume":"54","author":"BL Banwell","year":"2000","unstructured":"Banwell BL and Engel AG (2000) AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54: 1033\u20131041","journal-title":"Neurology"},{"issue":"Suppl 1","key":"BFncprheum0140_CR47","first-page":"A331","volume":"64","author":"J Schmidt","year":"2005","unstructured":"Schmidt J et al. (2005) Distinct interplay between inflammatory and degeneration-associated molecules in sporadic IBM. Neurology 64 (Suppl 1): A331\u2013A332","journal-title":"Neurology"},{"key":"BFncprheum0140_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1212\/WNL.57.5.755","volume":"57","author":"SA Greenberg","year":"2001","unstructured":"Greenberg SA (2001) DNA microarray gene expression analysis technology and its application to neurological disorders. Neurology 57: 755\u2013761","journal-title":"Neurology"},{"key":"BFncprheum0140_CR49","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awh518","volume":"128","author":"R Raju","year":"2005","unstructured":"Raju R and Dalakas MC (2005) Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128: 1887\u20131896","journal-title":"Brain"},{"key":"BFncprheum0140_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/01.WNL.0000071852.27182.C7","volume":"61","author":"C Lindberg","year":"2003","unstructured":"Lindberg C et al. (2003) Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study. Neurology 61: 260\u2013262","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1038\/ncprheum0220","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000}}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0140","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncprheum0140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:57:44Z","timestamp":1684429064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BFncprheum0140"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0140","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/ncprheum0220","asserted-by":"object"}]},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}